Literature DB >> 2253827

Arrest of glomerulopathy in diabetic dogs by improved glycaemic control.

T S Kern1, R L Engerman.   

Abstract

In order to assess the extent to which the progression of diabetic glomerulopathy can be arrested or reversed by improved glycaemic control, glomerular structure has been assessed in dogs randomly divided between a non-diabetic group and three alloxan diabetic groups: dogs assigned to poor glycaemic control for five years (PC), dogs assigned to good glycaemic control for five years (GC), and dogs assigned to poor glycaemic control for 2.5 years followed by good glycaemic control for 2.5 years (P----GC). Glomerular volume, the fractional volume of mesangium as estimated by light microscopy and thickness of glomerular basement membrane as estimated by electron microscopy were significantly greater than normal at 2.5 years of poor glycaemic control, and were even greater at five years. Kidney weight and the frequency of glomerular obliteration were significantly greater than normal at five years of poor control. The development of these renal abnormalities was significantly inhibited if good glycaemic control was begun within the first weeks of diabetes. Good control following 2.5 years of poor control (group P----GC) arrested the progression of the renal abnormalities, but no reversal of the lesions toward normal was apparent.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2253827     DOI: 10.1007/bf00404138

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  29 in total

1.  Improved diabetes control reduces skeletal muscle capillary basement membrane width in insulin-dependent diabetes mellitus.

Authors:  J Rosenstock; P Challis; S Strowig; P Raskin
Journal:  Diabetes Res Clin Pract       Date:  1988-02-19       Impact factor: 5.602

2.  Drug-induced reversal of early diabetic microangiopathy.

Authors:  R A Camerini-Davalos; C Velasco; M Glasser; J M Bloodworth
Journal:  N Engl J Med       Date:  1983-12-22       Impact factor: 91.245

3.  Effect of blood glucose control on increased glomerular filtration rate and kidney size in insulin-dependent diabetes.

Authors:  M J Wiseman; A J Saunders; H Keen; G Viberti
Journal:  N Engl J Med       Date:  1985-03-07       Impact factor: 91.245

4.  Irreversibility of glomerular basement membrane accumulation despite reversibility of renal hypertrophy with islet transplantation in early experimental diabetes.

Authors:  O Gøtzsche; H J Gundersen; R Osterby
Journal:  Diabetes       Date:  1981-06       Impact factor: 9.461

5.  Progression of incipient diabetic retinopathy during good glycemic control.

Authors:  R L Engerman; T S Kern
Journal:  Diabetes       Date:  1987-07       Impact factor: 9.461

6.  Prevention of diabetic glomerulopathy in streptozotocin diabetic rats by insulin treatment.

Authors:  R Rasch
Journal:  Diabetologia       Date:  1979-05       Impact factor: 10.122

7.  Muscle capillary basement-membrane thickness and long-term glycemia in type I diabetes mellitus.

Authors:  J M Sosenko; O S Miettinen; J R Williamson; K H Gabbay
Journal:  N Engl J Med       Date:  1984-09-13       Impact factor: 91.245

8.  Long term correction of hyperglycaemia and progression of renal failure in insulin dependent diabetes.

Authors:  G C Viberti; R W Bilous; D Mackintosh; J J Bending; H Keen
Journal:  Br Med J (Clin Res Ed)       Date:  1983-02-19

9.  Effect of insulin therapy on established diabetic nephropathy in rats.

Authors:  J Petersen; J Ross; R Rabkin
Journal:  Diabetes       Date:  1988-10       Impact factor: 9.461

10.  The effects of pancreas transplantation on the glomerular structure of renal allografts in patients with insulin-dependent diabetes.

Authors:  R W Bilous; S M Mauer; D E Sutherland; J S Najarian; F C Goetz; M W Steffes
Journal:  N Engl J Med       Date:  1989-07-13       Impact factor: 91.245

View more
  10 in total

1.  Regulatory role of eicosanoids in extracellular matrix overproduction induced by long-term exposure to high glucose in cultured rat mesangial cells.

Authors:  F Pricci; G Pugliese; P Menè; G Romeo; G Romano; G Galli; A Casini; C M Rotella; U DiMario; F Pugliese
Journal:  Diabetologia       Date:  1996-09       Impact factor: 10.122

2.  Vitamin E and probucol reduce urinary lipophilic aldehydes and renal enlargement in streptozotocin-induced diabetic rats.

Authors:  S S Kim; D D Gallaher; A S Csallany
Journal:  Lipids       Date:  2000-11       Impact factor: 1.880

Review 3.  The link between hyperglycaemia and diabetic nephropathy.

Authors:  R G Larkins; M E Dunlop
Journal:  Diabetologia       Date:  1992-06       Impact factor: 10.122

4.  Effects of the start time of glycemic control on erectile function in streptozotocin-induced diabetic rats.

Authors:  O Kwon; S Y Cho; J-S Paick; S W Kim
Journal:  Int J Impot Res       Date:  2016-09-22       Impact factor: 2.896

5.  Effect of myo-inositol supplementation on the development of renal pathological changes in the Cohen diabetic (type 2) rat.

Authors:  A M Cohen; H Wald; M Popovtzer; E Rosenmann
Journal:  Diabetologia       Date:  1995-08       Impact factor: 10.122

Review 6.  Salt, hypertension and renal disease: comparative medicine, models and real diseases.

Authors:  A R Michell
Journal:  Postgrad Med J       Date:  1994-10       Impact factor: 2.401

Review 7.  Alterations of glomerular matrix proteins in the pathogenesis of diabetic nephropathy.

Authors:  B Olgemöller; E Schleicher
Journal:  Clin Investig       Date:  1993

8.  Longitudinal prevalence of hypertension, proteinuria, and retinopathy in dogs with spontaneous diabetes mellitus.

Authors:  I P Herring; D L Panciera; S R Werre
Journal:  J Vet Intern Med       Date:  2014-01-13       Impact factor: 3.333

Review 9.  Animal Models of Diabetes-Associated Renal Injury.

Authors:  Zahra Samadi Noshahr; Hossein Salmani; Abolfazl Khajavi Rad; Amirhossein Sahebkar
Journal:  J Diabetes Res       Date:  2020-05-20       Impact factor: 4.011

Review 10.  An Update on the Use of Animal Models in Diabetic Nephropathy Research.

Authors:  Boris Betz; Bryan R Conway
Journal:  Curr Diab Rep       Date:  2016-02       Impact factor: 4.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.